Climb Bio PT raised to $32 from $20 by BTIG
BTIG raised its price target for Climb Bio to $32.00 per share from $20.00, while maintaining a Buy rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.